Catalyst to Speak on FDA & Innovation, Market Trends Affecting the Future of Health Care, and RWE in Drug Development
Catalyst Healthcare Consulting will be speaking at a number of events this spring and summer. Come join us as we explore some of the key issues and trends impacting the environment for medical product development.
Catalyst President Nancy Bradish Myers will moderate or participate in several panels at US and international conferences over the next few months:
- Drug Information Association (DIA) 2018, Boston:
- Moderator: FDA innovation in the Gottlieb era – “DIAmond Session,” June 25
- Moderator: 2018 Policy Mash-Up: New Shifts in the Healthcare Market and What They May Mean for Patients and the Biopharma Industry – June 26
- DIA China 2018, Beijing:
- Panelist: “Real-world Evidence Defined and Re-defined: Regulatory and Practical Considerations for Drug Development”